Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Immunex and Genentech reach TRAIL/Apo2L oncology agreement

June 7, 1999

New carbazole from Kyowa Hakko effective against chemotherapy-induced thrombocytopenia

June 4, 1999

Introgen Therapeutics commences phase I trial of i.v. p53 gene therapy

June 4, 1999

Spotlight on protein farnesyltransferase inhibitors

June 4, 1999

Phase II ECOG trial of didemnin B in melanoma patients yields indeterminate results

June 4, 1999

Rigel identifies cancer- and inflammation-related gene

June 4, 1999

Study indicates potential of KRN-5500 in the treatment of leukemia and lymphoma

June 3, 1999

U. of Alberta designs new bis-benzimidazole anticancer agents

June 3, 1999

Academic investigators describe new agent for BNCT

June 3, 1999

Merck researchers discover nonpeptide GnRH antagonist series

June 3, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...